Drug Trial Radar · NCT05109312
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. Master Protocol HTX-011-401.
Last checked: Nov 20, 2026Latest source record: Oct 26, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Oct 12, 2021
Primary completion
Jun 2024
Study completion Jun 2024
Sponsor
- Lead sponsor
- Heron TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Nov 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing different surgical procedures. Each parallel cohort will enroll subjects undergoing a unique surgical procedure: total shoulder arthroplasty (TSA) in Cohort 1 and abdominoplasty in Cohort 2.
Conditions
- Analgesia
Interventions
Bupivacaine HydrochlorideDrug
100 mg
Bupivacaine HydrochlorideDrug
125 mg
HTX-011Drug
400 mg
Luer lock applicatorDevice
Applicator for instillation
IbuprofenDrug
400 mg
AcetaminophenDrug
1 g
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events (TEAEs).Time frame: Through Day 15
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Woodland International Research Group, LLC
Little Rock, Arkansas
Gulfcoast Research Institute
Sarasota, Florida
The Orthopaedic Center
Tulsa, Oklahoma
First Surgical Hospital
Bellaire, Texas
Legent Orthopedic Hospital
Carrollton, Texas
Endeavor Clinical Trials, LLC
San Antonio, Texas
JBR Clinical Research
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.